Domain Partners
Venture capitalPrinceton
Fund manager profile
Domain Partners is a venture fund manager based in Princeton. SEC filings show 1 venture fund on record, most recently Domain Partners IX, L.P. filed December 2016.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 5 of 6 portfolio companiesBiotech ×4Healthtech ×3Medical Devices ×2AI & Machine Learning ×1
HQs:United States×6
Investments · 6 tracked
founders shown can be your intro pathBy year:2017 · 22016 · 32015 · 16 dated
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Amir Nashat(Non-Management Director)Paul Schimmel(Non-Management Director)Akkaraju Srinivas(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Ed Penhoet(Non-Management Director)
Board seatJames C. Blair· per SEC Form D · $76.3M raise · filed Apr 2015
BiotechBoston, US
SARKIS K. MAZMANIAN(Director)JAMES C. BLAIR(Director)Ronald C. Renaud Jr.(Director)DAVID H. DONABEDIAN(CHIEF EXECUTIVE OFFICER OF THE ISSUER)MICHELLE DIPP(Director)Henry Wolf(Director)
Board seatJames C. Blair· per SEC Form D · $19.1M raise · filed Jun 2017
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Board seatJames C. Blair· per SEC Form D · $12.1M raise · filed Apr 2017
HealthtechSanta Clara, US
Hanson Gifford III(Director)Henry Plain, Jr.(Director)R. Michael Kleine(Executive Officer, Director)Nimesh Shah(Director)Stacy Seltzer(Director)Brigid Makes(Executive Officer)
Board seatBrian H. Dovey· per SEC Form D · $33.6M raise · filed Jun 2016
BiotechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Brian H. Dovey(Director)Louis C Bock(Director)Patrick J Mahaffy(Director)Lota S Zoth(Director)
Board seatBrian H. Dovey· per SEC Form D · $49.6M raise · filed Mar 2017
Lake Forest, US
John T. Kilcoyne(Executive Officer, Director)Renee Ryan(Director)Gilbert H. Kliman(Director)Andy Corley(Director)Inna Martin Eitan(Director)Louis Bunn(Executive Officer)
Board seatBrian H. Dovey· per SEC Form D · $45M raise · filed Nov 2016
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioaTYR PHARMANASDAQ: ATYR
Fund performance · per public LP disclosures · 2
as of Jun 2020| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Domain Partners VII, L.P.LPs: The Regents of the University of California | 2006 | — | -1.4% | 0.95x | 0.95x |
| Domain Partners VI, L.P.LPs: The Regents of the University of California | 2003 | — | -4.8% | 0.81x | 0.81x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- Where is Domain Partners located?
- Domain Partners is headquartered in Princeton, US.